Evidence map›Paper›PMID 32655566›Full record

ReviewFrontiers in immunology2020

Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair.

Laura Farr, Swagata Ghosh, Shannon Moonah

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 157 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Targeted intestinal barrier repairActa pharmaceutica Sinica. B · 2026
    Article
  9. Article
  10. Acellular Adipose Tissue promotes anti-fibrotic remodeling in Phase II Study.medRxiv : the preprint server for health sciences · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Laura FarrDepartment of Medicine, University of Virginia, Charlottesville, VA, United States.
Swagata GhoshDepartment of Medicine, University of Virginia, Charlottesville, VA, United States.
Shannon MoonahDepartment of Medicine, University of Virginia, Charlottesville, VA, United States.
University of Virginia · US

Funding

STRUCTURE/FUNCTION OF E HISTOLYTICA ADHERENCE LECTINR01AI026649 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI PETRI, WILLIAM A · 1989 to 2016
$6.1M
Role of the Pro-inflammatory MIF Homolog of Entamoeba histolytica in ColitisK08AI119181 · NIAID · UNIVERSITY OF VIRGINIA · PI MOONAH, SHANNON · 2016 to 2020
$946k
NIAID NIH HHS K08 AI119181NIAID NIH HHS R01 AI026649
6 · The paper itself

Abstract

Wound healing after an injury is essential for life. An in-depth understanding of the healing process is necessary to ultimately improve the currently limited treatment options for patients suffering as a result of damage to various organs and tissues. Injuries, even the most minor, trigger an inflammatory response that protects the host and activates repair pathways. In recent years, substantial progress has been made in delineating the mechanisms by which inflammatory cytokines and their receptors facilitate tissue repair and regeneration. This mini review focuses on emerging literature on the role of the cytokine macrophage migration inhibitory factor (MIF) and its cell membrane receptor CD74, in protecting against injury and promoting healing in different parts of the body.

Indexed as

AnimalsAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIHumansMacrophage Migration-Inhibitory FactorsRegenerationSignal TransductionWound HealingAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IIinvariant chainMacrophage Migration-Inhibitory FactorsCD74 receptorcytokinesinflammatory bowel disease (IBD)ischemia-reperfusion injury (I/R)lung injurymacrophage migration inhibitory factor (MIF)regenerationwound healing

Identifiers

PMID32655566
PMCPMC7325688
OpenAlexW3037246116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.